• Return to Headlines

26.1% Return Seen to Date on SmarTrend Ptc Therapeutics Call (PTCT)

By Shiri Gupta

SmarTrend identified an Uptrend for Ptc Therapeutics (NASDAQ:PTCT) on May 2nd, 2018 at $30.10. In approximately 1 month, Ptc Therapeutics has returned 26.13% as of today's recent price of $37.96.

Ptc Therapeutics share prices have moved between a 52-week high of $38.52 and a 52-week low of $14.56 and are now trading 161% above that low price at $38.00 per share. Over the past week, the 200-day moving average (MA) has gone up 1.3% while the 50-day MA has advanced 2.2%.

PTC Therapeutics, Inc. provides biopharmaceutical products. The Company develops orally administered and small-molecule drugs for genetic disorders, oncology, and infectious disease. PTC Therapeutics operates in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Ptc Therapeutics shares.

Log in and add Ptc Therapeutics (PTCT) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights ptc therapeutics

Ticker(s): PTCT